Hence, we proposed the modulation of PPARγ axis and its down-stream effectors (NF-κB and HO-1) as a possible mechanism supporting the anti-inflammatory effects of MSCs-derived EVs in CF [74]. The gene discussed is PPARG; the disease is cystic fibrosis.